As of January 12, 2023, COVID-19 has been responsible for 202,157 deaths in the UK overall. The North West of England has been the most affected area in terms of deaths at 28,116, followed by the South East of England with 26,221 coronavirus deaths. Furthermore, there have been 22,264 mortalities in London as a result of COVID-19.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

Headline estimates for England, Wales, Northern Ireland and Scotland. 

Dataset from the Opinions and Lifestyle Survey (OPN) on the likelihood of children aged between 12 and 15 years receiving a coronavirus (COVID-19) vaccine.

This file contains workforce absence statistics for education settings from 12 October 2020 to 17 December 2020 and again following wider reopening of schools, from 8 March 2021 to 16 September 2021. It excludes half term terms (19th October - 23rd October, and 2nd November 2020), the national lockdown during the spring term (4 January to 5 March 2021), Easter data (29 March - 19 April 2021) and summer holiday (17 July 2021 - 6 September 2021). Data for workforce during the restricted opening of schools can be found in table 1e.Data is in this file has been scaled to account for non-response so it is nationally representative.

The number of COVID-19 vaccination doses administered in the United Kingdom rose to 151248820 as of Oct 27 2023. This dataset includes a chart with historical data for the United Kingdom Coronavirus Vaccination Total.

Figures on coronavirus (COVID-19) vaccine uptake in school pupils aged 12 to 17 years attending state-funded secondary, sixth form and special schools, broken down by demographic and geographic characteristics, using a linked English Schools Census and National Immunisation Management System dataset. Experimental Statistics.

Vaccinations in London Between 8 December 2020 and 15 September 2021 5,838,305 1st doses and 5,232,885 2nd doses have been administered to London residents.

Differences in vaccine roll out between London and the Rest of England London Rest of England Priority Group Vaccinations given Percentage vaccinated Vaccinations given Percentage vaccinated Group 1 Older Adult Care Home Residents 21,883 95% 275,964 96% Older Adult Care Home Staff 29,405 85% 381,637 88% Group 2 80+ years 251,021 83% 2,368,284 93% Health Care Worker 174,944 99% 1,139,243 100%* Group 3 75 - 79 years 177,665 90% 1,796,408 99% Group 4 70 - 74 years 252,609 90% 2,454,381 97% Clinically Extremely Vulnerable 278,967 88% 1,850,485 95% Group 5 65 - 69 years 285,768 90% 2,381,250 97% Group 6 At Risk or Carer (Under 65) 983,379 78% 6,093,082 88% Younger Adult Care Home Residents 3,822 92% 30,321 93% Group 7 60 - 64 years 373,327 92% 2,748,412 98% Group 8 55 - 59 years 465,276 91% 3,152,412 97% Group 9 50 - 54 years 510,132 90% 3,141,219 95% Data as at 15 September 2021 for age based groups and as at 12 September 2021 for non-age based groups * The number who have received their first dose exceeds the latest official estimate of the population for this group There is considerable uncertainty in the population denominators used to calculate the percentage vaccinated. Comparing implied vaccination rates for multiple sources of denominators provides some indication of uncertainty in the true values. Confidence is higher where the results from multiple sources agree more closely. Because the denominator sources are not fully independent of one another, users should interpret the range of values across sources as indicating the minimum range of uncertainty in the true value. The following datasets can be used to estimate vaccine uptake by age group for London:

ONS 2020 mid-year estimates (MYE). This is the population estimate used for age groups throughout the rest of the analysis.


Number of people ages 18 and over on the National Immunisation Management Service (NIMS)


ONS Public Health Data Asset (PHDA) dataset. This is a linked dataset combining the 2011 Census, the General Practice Extraction Service (GPES) data for pandemic planning and research and the Hospital Episode Statistics (HES). This data covers a subset of the population.

Vaccine roll out in London by Ethnic Group Understanding how vaccine uptake varies across different ethnic groups in London is complicated by two issues:

Ethnicity information for recipients is unavailable for a very large number of the vaccinations that have been delivered. As a result, estimates of vaccine uptake by ethnic group are highly sensitive to the assumptions about and treatment of the Unknown group in calculations of rates.

For vaccinations given to people aged 50 and over in London nearly 10% do not have ethnicity information available,

The accuracy of available population denominators by ethnic group is limited. Because ethnicity information is not captured in official estimates of births, deaths, and migration, the available population denominators typically rely on projecting forward patterns captured in the 2011 Census. Subsequent changes to these patterns, particularly with respect to international migration, leads to increasing uncertainty in the accuracy of denominators sources as we move further away from 2011.

Comparing estimated population sizes and implied vaccination rates for multiple sources of denominators provides some indication of uncertainty in the true values. Confidence is higher where the results from multiple sources agree more closely. Because the denominator sources are not fully independent of one another, users should interpret the range of values across sources as indicating the minimum range of uncertainty in the true value. The following population estimates are available by Ethnic group for London:

GLA Ethnic group population projections - 2016 as at 2021


ONS Population Denominators produced for Race Disparity Audit as at 2018


ETHPOP population projections produced by the University of Leeds as at 2020

Antibody prevalence estimates As part of the ONS Coronavirus (COVID-19) Infection Survey ONS publish a modelled estimate of the percent of the adult population testing positive for antibodies to Coronavirus by region. Antibodies can be generated by vaccination or previous infection.

Vaccine effects on cases, hospitalisations and deaths When the vaccine roll out began in December 2020 coronavirus cases, hospital admissions and deaths were rising steeply. The peak of infections came in London in early January 2021, before reducing during the national lockdown and as the vaccine roll out progressed. As the vaccine roll out began in older age groups the effect of vaccinations can be separated from the effect of national lockdown by comparing changes in cases, admissions and deaths

The outbreak of the novel coronavirus in the United Kingdom has caused an increase in consumer spending in grocery stores across the country. Compared to the same period in the previous year sales in the 12 week period ending on the 22nd of March have increased by double digits for Aldi, Iceland, Ocado and Lidl. With Lidl showing the biggest growth in sales with 17.6 percent. Morrisons showed the smallest growth in sales with 4.6 percent. Of the big four supermarkets (Asda, Sainsbury's, Teso and Morrisons), Sainsbury's saw the biggest increase in sales numbers.

United Kingdom recorded 344 Coronavirus Recovered since the epidemic began, according to the World Health Organization (WHO). In addition, United Kingdom reported 148003 Coronavirus Deaths. This dataset includes a chart with historical data for the United Kingdom Coronavirus Recovered.

CVD-COVID-UK, co-ordinated by the British Heart Foundation (BHF) Data Science Centre (https://bhfdatasciencecentre.org/), is one of the NIHR-BHF Cardiovascular Partnership’s National Flagship Projects.

CVD-COVID-UK aims to understand the relationship between COVID-19 and cardiovascular diseases through analyses of de-identified, pseudonymised, linked, nationally collated health datasets across the four nations of the UK. The consortium has over 400 members across more than 50 institutions including data custodians, data scientists and clinicians, all of whom have signed up to an agreed set of principles with an inclusive, open and transparent ethos.

Approved researchers access data within secure trusted/secure research environments (TREs/SDEs) provided by NHS England (England), the National Safe Haven (Scotland), the SAIL Databank (Wales) and the Honest Broker Service (Northern Ireland). A dashboard of datasets available in each nation’s TRE can be found here: https://bhfdatasciencecentre.org/areas/cvd-covid-uk-covid-impact/

This dataset represents the linked datasets for CVD-COVID-UK in the National Safe Haven for Scotland and contains the following datasets: • Outpatient Appointments and Attendances - Scottish Morbidity Record (SMR00) • General Acute Inpatient and Day Case - Scottish Morbidity Record (SMR01) • Scotland Accident and Emergency • COVID-19 Tests (lab/lighthouse testing) • SARS-CoV-2 viral sequencing data (COG-UK data) - Lineage/Variant Data - Scotland • Scottish Covid-19 Vaccination Data • National Records of Scotland (NRS) - Deaths Data • SICSAG Daily (Scottish Intensive Care Audit Group) • SICSAG Episodes (Scottish Intensive Care Audit Group) • Prescribing Information System (PIS) • Scottish Stroke Care Audit • Diabetes covariates • Scottish Renal Registry

The dataset contains a weekly situation update on COVID-19, the epidemiological curve and the global geographical distribution (EU/EEA and the UK, worldwide).

Since the beginning of the coronavirus pandemic, ECDC’s Epidemic Intelligence team has collected the number of COVID-19 cases and deaths, based on reports from health authorities worldwide. This comprehensive and systematic process was carried out on a daily basis until 14/12/2020. See the discontinued daily dataset: COVID-19 Coronavirus data - daily. ECDC’s decision to discontinue daily data collection is based on the fact that the daily number of cases reported or published by countries is frequently subject to retrospective corrections, delays in reporting and/or clustered reporting of data for several days. Therefore, the daily number of cases may not reflect the true number of cases at EU/EEA level at a given day of reporting. Consequently, day to day variations in the number of cases does not constitute a valid basis for policy decisions.

ECDC continues to monitor the situation. Every week between Monday and Wednesday, a team of epidemiologists screen up to 500 relevant sources to collect the latest figures for publication on Thursday. The data screening is followed by ECDC’s standard epidemic intelligence process for which every single data entry is validated and documented in an ECDC database. An extract of this database, complete with up-to-date figures and data visualisations, is then shared on the ECDC website, ensuring a maximum level of transparency.

ECDC receives regular updates from EU/EEA countries through the Early Warning and Response System (EWRS), The European Surveillance System (TESSy), the World Health Organization (WHO) and email exchanges with other international stakeholders. This information is complemented by screening up to 500 sources every day to collect COVID-19 figures from 196 countries. This includes websites of ministries of health (43% of the total number of sources), websites of public health institutes (9%), websites from other national authorities (ministries of social services and welfare, governments, prime minister cabinets, cabinets of ministries, websites on health statistics and official response teams) (6%), WHO websites and WHO situation reports (2%), and official dashboards and interactive maps from national and international institutions (10%). In addition, ECDC screens social media accounts maintained by national authorities on for example Twitter, Facebook, YouTube or Telegram accounts run by ministries of health (28%) and other official sources (e.g. official media outlets) (2%). Several media and social media sources are screened to gather additional information which can be validated with the official sources previously mentioned. Only cases and deaths reported by the national and regional competent authorities from the countries and territories listed are aggregated in our database.

Disclaimer: National updates are published at different times and in different time zones. This, and the time ECDC needs to process these data, might lead to discrepancies between the national numbers and the numbers published by ECDC. Users are advised to use all data with caution and awareness of their limitations. Data are subject to retrospective corrections; corrected datasets are released as soon as processing of updated national data has been completed.

If you reuse or enrich this dataset, please share it with us.

Odds ratios for symptoms reported at least 12 weeks after coronavirus (COVID-19) infection, comparing Coronavirus (COVID-19) Infection Survey participants who had received two doses of a COVID-19 vaccine before infection with those who were unvaccinated: 26 January 2022.

The coronavirus outbreak has had a huge impact on retail locations in the United Kingdom (UK). Since mid-March, footfall in UK retail locations (including high streets, shopping centers and retail parks) fell the sharpest on April 12, coinciding with Easter, with a decline of **** percent.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Fact and Figures page.

Context

• The dataset contains the latest available public data on COVID-19 including a daily situation update, the epidemiological curve and the global geographical distribution (EU/EEA and the UK, worldwide).
• On 12 February 2020, the novel coronavirus was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) while the disease associated with it is now referred to as COVID-19.
• ECDC is closely monitoring this outbreak and providing risk assessments to guide EU Member States and the EU Commission in their response activities.

Geographical Coverage

Slovakia, Finland, Sweden, United Kingdom, Poland, Portugal, Romania, Slovenia, China, North Macedonia, Bulgaria, Belgium, Denmark, Czechia, Estonia, Germany, Greece, Ireland, France, Spain, Italy, Croatia, Latvia, Cyprus, Luxembourg, Lithuania, Malta, Hungary, Austria, Netherlands, Russia, Norway, Switzerland

Acknowledgements

https://data.europa.eu/euodp/en/data/dataset/covid-19-coronavirus-data